These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2129320)

  • 1. Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment.
    Jay RH; Rampling MW; Betteridge DJ
    Atherosclerosis; 1990 Dec; 85(2-3):249-56. PubMed ID: 2129320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology and fibrinogen in children with familial hypercholesterolaemia.
    Jay RH; McCarthy SN; Rampling MW; Betteridge DJ
    Atherosclerosis; 1991 Nov; 91(1-2):117-21. PubMed ID: 1811547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
    Wiklund O; Angelin B; Fager G; Eriksson M; Olofsson SO; Berglund L; Lindén T; Sjöberg A; Bondjers G
    J Intern Med; 1990 Sep; 228(3):241-7. PubMed ID: 2119417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
    Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
    Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment.
    Banyai S; Banyai M; Falger J; Jansen M; Alt E; Derfler K; Koppensteiner R
    Atherosclerosis; 2001 Dec; 159(2):513-9. PubMed ID: 11730833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.
    Wiklund O; Angelin B; Olofsson SO; Eriksson M; Fager G; Berglund L; Bondjers G
    Lancet; 1990 Jun; 335(8702):1360-3. PubMed ID: 1971660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia.
    Martinez M; Vaya A; Marti R; Gil L; Lluch I; Carmena R; Aznar J
    Haemostasis; 1996 Oct; 26 Suppl 4():171-6. PubMed ID: 8979121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein(a)?
    Koenig W; Hehr R; Ditschuneit HH; Kuhn K; Ernst E; Rosenthal J; Hombach V
    J Clin Pharmacol; 1992 Jun; 32(6):539-45. PubMed ID: 1634641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels.
    Beigel Y; Fuchs J; Snir M; Lurie Y; Green P; Djaldetti M
    J Intern Med; 1991 Jul; 230(1):23-7. PubMed ID: 2066708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
    Tsuda Y; Satoh K; Kitadai M; Takahashi T; Izumi Y; Hosomi N
    Atherosclerosis; 1996 May; 122(2):225-33. PubMed ID: 8769685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
    Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR
    BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lovastatin on hemorheology in type II hyperlipoproteinemia.
    Koppensteiner R; Minar E; Ehringer H
    Atherosclerosis; 1990 Jul; 83(1):53-8. PubMed ID: 2390136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients.
    Miossec P; Zkhiri F; Pariès J; David-Dufilho M; Devynck MA; Valensi PE
    Diabet Med; 1999 May; 16(5):424-30. PubMed ID: 10342343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Schwartzkopff W; Bimmermann A; Schleicher J
    Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorheological effects of secoisolariciresinol in ovariectomized rats.
    Maslov MY; Plotnikova TM; Anishchenko AM; Aliev OI; Nifantiev NE; Plotnikov MB
    Biorheology; 2016 Jan; 53(1):23-31. PubMed ID: 26756280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine.
    Kume N; Kita T; Mikami A; Yokode M; Ishii K; Nagano Y; Kawai C
    Circulation; 1989 May; 79(5):1084-90. PubMed ID: 2496935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
    Wiek J; Krause M; Wiederholt M; Hansen LL
    Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.